News & Updates
Filter by Specialty:
Neoplastic progression to pancreatic cancer slips by imaging surveillance
Imaging-based surveillance techniques may miss hallmarks of progression in high-risk individuals presenting with high-grade dysplasia or pancreatic cancer, suggesting a need for more sensitive tools, a recent study has found.
Neoplastic progression to pancreatic cancer slips by imaging surveillance
08 Mar 2022
Immune-related adverse events portend better prognosis in ICI-treated hepatocellular carcinoma
Among advanced hepatocellular carcinoma patients being treated with immune checkpoint inhibitors (ICIs), the occurrence of multisystem and more severe immune-related adverse events is a favourable signal, being associated with survival advantage, according to a Singapore study.
Immune-related adverse events portend better prognosis in ICI-treated hepatocellular carcinoma
08 Mar 2022
Adding capecitabine to adjuvant chemo improves 15-year OS in early breast cancer
Adding capecitabine to adjuvant chemotherapy containing docetaxel, epirubicin and cyclophosphamide significantly improves 15-year overall survival (OS) in patients with early breast cancer, results of the phase III FinXX trial (Finland Capecitabine Trial) have shown.
Adding capecitabine to adjuvant chemo improves 15-year OS in early breast cancer
07 Mar 2022
AChEI use ups lung cancer risk in older, comorbid patients
Medication with acetylcholinesterase inhibitors (AChEI) increases the risk of lung cancer among older patients and those with several comorbidities, reports a recent study.
AChEI use ups lung cancer risk in older, comorbid patients
07 Mar 2022
T2D risk elevated in thyroid cancer patients after thyroidectomy
Development of type 2 diabetes (T2D) is more likely to occur among patients with thyroid cancer who underwent thyroidectomy than matched controls, a Korea study has shown. In addition, a U-shaped dose-dependent relationship exists between the levothyroxine dosage and T2D risk.